# The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics

> **NCT00951899** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 38 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Colesevelam
- **OTHER:** Placebo
- **BEHAVIORAL:** Diet
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00951899
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-07
- **Final completion:** 2012-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2013-11-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951899, "The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00951899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*